Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/BF00590929 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
).
J Med Food
January 2025
Laboratory of Applied Microbiology, Faculty of Sciences of Nature and Life, University Ferhat Abbes Sétif 1, Sétif, Algeria.
L., or "Sedra" in North Africa, is a wild jujube from the Rhamnaceae family. Its fruit, "Nbeg," is used in traditional medicine to treat various ailments, such as tuberculosis, bronchitis, liver disorders, and gastrointestinal issues.
View Article and Find Full Text PDFAntioxidant activity and Inhibitory effects of Cydonia oblonga Miller. leaves extracts against calcium oxalate stones.
Urolithiasis
April 2024
Laboratory of Applied Spectro-Chemometry and Environment, Faculty of Sciences and Technologies, Sultan Moulay Slimane University, Beni Mellal, Morocco.
Urinary stone disease is a widespread health problem in both adults and children, and its prevalence has been increasing worldwide. Various plants preparations have already been used since ancient times in order to treat urolithiasis. The aim of this study is to evaluate the antioxidant capacity and litholytic effect on kidney stones of Cydonia oblonga Miller.
View Article and Find Full Text PDFIntroduction: Urolithiasis is one of the most common urological diseases in adults. Increased life expectancy of the population in developed countries, make urolithiasis topical issue and requires close attention. Due to the high risk of recurrent stone formation causing repeated surgical interventions, the issue of effective urinary stone metaphylaxis is very important today.
View Article and Find Full Text PDF[Ursodeoxycholic acid: history and clinical implications].
Ned Tijdschr Geneeskd
September 2022
Amsterdam UMC, Amsterdam; Gastroenterology Endocrinology Metabolism (AGEM) Research Institute;Tytgat Institute for Liver and Intestinal Research, Department of Gastroenterology and Hepatology, Amsterdam.
The physiologic bile acid ursodeoxycholic acid (UDCA) has potent anticholestatic and weak litholytic properties and has been used for centuries as a remedy for cholestatic liver diseases. Today, UDCA at 13-15 mg/kg/day is the standard first line medication for all people with primary biliary cholangitis (PBC), the most frequent chronic cholestatic liver disease where UDCA clearly improves long-term survival. For many other chronic cholestatic conditions, anticholestatic effects are described, but long-term data are incomplete.
View Article and Find Full Text PDFEfficacy of Chenodeoxycholic Acid and Ursodeoxycholic Acid Treatments for Refractory Functional Dyspepsia.
J Clin Med
June 2022
Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul 06273, Korea.
Refractory functional dyspepsia (RFD) is diagnosed when symptoms persist for at least 6 months despite at least two medical treatments. No consensus treatment guidelines exist. The implicated causes of functional biliary dyspepsia are a narrowed cystic duct, Sphincter of Oddi dysfunction, microlithiasis, and gallbladder dyskinesia.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!